Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP623525.RAU0StfThlYGdPa_RvUe9djf_JNCAfQfgKdfsqsuYUCqo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP623525.RAU0StfThlYGdPa_RvUe9djf_JNCAfQfgKdfsqsuYUCqo130_assertion type Assertion NP623525.RAU0StfThlYGdPa_RvUe9djf_JNCAfQfgKdfsqsuYUCqo130_head.
- NP623525.RAU0StfThlYGdPa_RvUe9djf_JNCAfQfgKdfsqsuYUCqo130_assertion wasGeneratedBy ECO_0000203 NP623525.RAU0StfThlYGdPa_RvUe9djf_JNCAfQfgKdfsqsuYUCqo130_provenance.
- NP623525.RAU0StfThlYGdPa_RvUe9djf_JNCAfQfgKdfsqsuYUCqo130_assertion wasDerivedFrom befree-20140225 NP623525.RAU0StfThlYGdPa_RvUe9djf_JNCAfQfgKdfsqsuYUCqo130_provenance.
- NP623525.RAU0StfThlYGdPa_RvUe9djf_JNCAfQfgKdfsqsuYUCqo130_assertion SIO_000772 10363563 NP623525.RAU0StfThlYGdPa_RvUe9djf_JNCAfQfgKdfsqsuYUCqo130_provenance.
- NP623525.RAU0StfThlYGdPa_RvUe9djf_JNCAfQfgKdfsqsuYUCqo130_assertion evidence source_evidence_literature NP623525.RAU0StfThlYGdPa_RvUe9djf_JNCAfQfgKdfsqsuYUCqo130_provenance.
- NP623525.RAU0StfThlYGdPa_RvUe9djf_JNCAfQfgKdfsqsuYUCqo130_assertion description "[In terms of cancer types, all clear-cell adenocarcinomas and most of the serous-type adenocarcinomas expressed both NOS I and NOS II, while most uterine squamous carcinomas and endometrial adenocarcinomas expressed only NOS II.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP623525.RAU0StfThlYGdPa_RvUe9djf_JNCAfQfgKdfsqsuYUCqo130_provenance.